Endometrial receptivity test (ERA)
A biopsy that claims to find your personal 'window' for embryo transfer.
The verdict
Not shown to improve your chance of a baby.
| Body | Position |
|---|---|
| HFEA |
|
| ESHRE | Not recommended Not recommended for any patient group. Source |
| NICE | Do not offer (2026) NG257 1.41.1: do not offer endometrial receptivity testing as a treatment add-on (includes gene-expression arrays like ERA). Source |
| ISAR | No position Not addressed in the 2021 ISAR add-ons consensus. |
Cochrane evidence base
RCTs show no improvement in live birth from timing transfers this way.
In India
~₹35,000–55,000, plus a delayed/extra frozen cycle.
- The evidence does not support it. HFEA rates it red, NICE says do not offer it (2026), and randomised trials show no improvement in live birth from timing transfers this way.
Should I have an ERA test?
Sources
Take this further
Last reviewed .